無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

アカルボースの中国市場の分析

Investigation Report on China's Acarbose Market, 2018-2022

発行 China Research and Intelligence 商品コード 331522
出版日 ページ情報 英文 30 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=112.58円で換算しております。
Back to Top
アカルボースの中国市場の分析 Investigation Report on China's Acarbose Market, 2018-2022
出版日: 2018年11月01日 ページ情報: 英文 30 Pages
概要

当レポートでは、中国のアカルボース市場について調査分析し、発展環境、需要と供給、市場競合、価格、市場予測について、体系的な情報を提供しています。

第1章 アカルボースの関連概念

  • 適応
  • 中国の発展
  • 中国政府の承認

第2章 中国におけるアカルボースの売上

  • 売上高
  • 売上数量
  • 売上:剤形別

第3章 中国におけるアカルボース主要メーカーの分析

  • 市場シェア分析
  • Bayer
  • Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
  • Sichuan Luye Baoguang Pharmaceutical Co., Ltd.

第4章 中国におけるアカルボースの価格

  • Bayer (Glucobay)
  • Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (Kaboping)
  • Sichuan Luye Baoguang Pharmaceutical Co., Ltd. (Beixi)
  • Bayer (Glucobay)
  • Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (Kaboping)
  • Sichuan Luye Baoguang Pharmaceutical Co., Ltd. (Beixi)

第5章 中国のアカルボースの市場の見通し

  • 市場規模の予測
  • 市場動向の予測
目次
Product Code: 1811344

According to CRI, with improved living standards, ageing population, and increasing obesity rate, the incidence of diabetes has been climbing in China. By the end of 2017, the number of diabetic patients in China exceeded 100 million, ranking first in the world and promoting the development of the diabetes drug market.

Acarbose was developed by Bayer in 1975 and first launched in Switzerland in 1986 (trade name: Glucobay). As the first FDA-approved alpha-glycosidase inhibitor in the world, it entered China in 1994 and is now recommended as a first-line drug for type 2 diabetes. Acarbose is sold far better in China than in developed countries because it reduces glucose uptake mainly by inhibiting amylase and is more suitable for Asians who eat mainly carbohydrates.

Although Acarbose has been marketed in China for more than 20 years, China's Acarbose market is dominated by Bayer, Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. And Sichuan Luye Baoguang Pharmaceutical Co., Ltd. Because it is difficult to imitate Acarbose. In recent years, the market share of Bayer's Acarbose (trade name: Glucobay) is declining in China year by year, while the market share of domestic-made counterparts is rising. In 2017, the market size of Acarbose in China was about CNY 1.09 billion. Bayer's market share was about 66.4%, showing a continued momentum of decline.

According to CRI, from 2018 to 2022, the market size will continue to grow as the number of diabetic patients increases.

Topics Covered:

  • Development environment of Acarbose in China
  • Supply of and demand for Acarbose in China
  • Competition on China's Acarbose market
  • Prices of Acarbose in China
  • Forecasts on China's Acarbose market from 2018 to 2022

Table of Contents

1 Relevant Concepts of Acarbose

  • 1.1 Indications for Acarbose
  • 1.2 Development of Acarbose in China
  • 1.3 Governmental Approval of Acarbose in China

2 Sales of Acarbose in China, 2013-2017

  • 2.1 Sales Value of Acarbose
    • 2.1.1 Overall Sales Value
    • 2.1.2 Sales Value by Region
  • 2.2 Sales Volume of Acarbose
    • 2.2.1 Overall Sales Volume
    • 2.2.2 Sales Volume by Region
  • 2.3 Sales of Acarbose by Dosage Form in China, 2013-2017
    • 2.3.1 Capsules
    • 2.3.2 Tablets

3 Analysis on Major Acarbose Manufacturers in China, 2013-2017

  • 3.1 Analysis on Market Share of Major Acarbose Manufacturers
    • 3.1.1 Market Share by Sales Value
    • 3.1.2 Market Share by Sales Volume
  • 3.2 Bayer
    • 3.2.1 Enterprise Profile
    • 3.2.2 Sales of Bayer's Acarbose in China
  • 3.3 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
    • 3.3.1 Enterprise Profile
    • 3.3.2 Sales of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.'s Acarbose in China
  • 3.4 Sichuan Luye Baoguang Pharmaceutical Co., Ltd.
    • 3.4.1 Enterprise Profile
    • 3.4.2 Sales of Sichuan Luye Baoguang Pharmaceutical Co., Ltd.'s Acarbose in China

4 Prices of Acarbose in China, 2017-2018

  • 4.1 Bayer (Glucobay)
  • 4.2 Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. (Kaboping)
  • 4.3 Sichuan Luye Baoguang Pharmaceutical Co., Ltd. (Beixi)

5 Prospect of China's Acarbose Market, 2018-2022

  • 5.1 Forecast on Market Size
  • 5.2 Forecast on Market Trend

Selected Charts

  • Chart Governmental Approval of Acarbose in China
  • Chart Sales of Acarbose in China, 2013-2017
  • Chart Sales Value of Acarbose in Parts of China, 2013-2017
  • Chart Sales Volume of Acarbose in China, 2013-2017
  • Chart Sales Volume of Acarbose in Parts of China, 2013-2017
  • Chart Sales Value of Acarbose Capsules in China, 2013-2017
  • Chart Sales Volume of Acarbose Capsules in China, 2013-2017
  • Chart Sales Value of Acarbose Tablets in China, 2013-2017
  • Chart Market Share of Top 3 Acarbose Manufacturers by Sales Value in China, 2013-2017
  • Chart Sales Value of Bayer's Acarbose, 2013-2017
  • Chart Sales Volume of Bayer's Acarbose, 2013-2017
  • Chart Sales Value of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.'s Acarbose, 2013-2017
  • Chart Sales Volume of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.'s Acarbose, 2013-2017
  • Chart Sales Value of Sichuan Luye Baoguang Pharmaceutical Co., Ltd.'s Acarbose, 2013-2017
  • Chart Prices of Bayer's Acarbose (Glucobay) in Parts of China, 2017-2018
  • Chart Prices of Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.'s Acarbose in Parts of China, 2017-2018
  • Chart Prices of Sichuan Luye Baoguang Pharmaceutical Co., Ltd.'s Acarbose in Parts of China, 2017-2018
  • Chart Forecast on Sales Value of Acarbose in China, 2018-2022
Back to Top